Advancing the development of next-generation immunotherapies
Illuminating the immune landscape
ImmunoScape is an immunomics-focused company with a technology platform that allows for immune profiling and characterization of the human immune response at extremely high resolution.
The company’s Deep Immunomics platform combines mass cytometry, single cell sequencing, and proprietary computational bioinformatics, data analysis, and visualization tools to provide novel, reproducible immune profiling information.
This technology has been utilized across multiple therapeutic areas, especially in oncology and infectious disease, both to better understand immunotherapy safety and efficacy and to identify drug targets.
Tops News & Media Coverage
TCR upstart gets fresh funding as it looks to charge toward the clinic
Cancer Therapeutics Gaining Ground in APAC
Next-generation T-cell receptor (TCR) therapies can improve diagnosis and treatment regimens
Biotech startup ImmunoScape raises US$14m to further cancer therapy discoveries
ImmunoScape snags $14 million for technology platform targeting cancer